Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC
These data, published in The Journal for ImmunoTherapy of Cancer (JITC), demonstrate that TG6050 induces tumor regression and profound remodeling of the tumor microenvironment TG6050 has also shown to avoid toxicity associated with systemic administration …